Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon D Wagner

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2013
Cap-translation inhibitor, 4EGI-1, restores sensitivity to ABT-737 apoptosis through cap-dependent and -independent mechanisms in chronic lymphocytic leukemiaShaun Willimott, Daniel Beck, Matthew J Ahearne, et al.
Plos One|January 3, 2018
Circulating Tfh1 (cTfh1) cell numbers and PD1 expression are elevated in low-grade B-cell non-Hodgkin's lymphoma and cTfh gene expression is perturbed in marginal zone lymphomaElliot T Byford, Matthew Carr, Eleni Ladikou, et al.
Blood Advances|March 1, 2019
Interleukin-2-inducible T-cell kinase inhibitors modify functional polarization of human peripheral T-cell lymphoma cellsSami Mamand, Matthew Carr, Rebecca L Allchin, et al.
Virchows Archiv : an International Journal of Pathology|July 12, 2014
Expression of PD-1 (CD279) and FoxP3 in diffuse large B-cell lymphomaMatthew J Ahearne, Kaljit Bhuller, Roger Hew, et al.
The Biochemical Journal|February 24, 2010
ZEB1 and CtBP form a repressive complex at a distal promoter element of the BCL6 locusVasiliki Papadopoulou, Antonio Postigo, Ester Sánchez-Tilló, et al.
Leukemia & Lymphoma|August 19, 2007
Bcl-6 and c-Myc are rarely co-expressed in adult diffuse large B-cell lymphomaSimon D Wagner, Furrat Amen, Pritesh S Trivedi, et al.
BMC Research Notes|May 10, 2018
An increased fraction of circulating miR-363 and miR-16 is particle bound in patients with chronic lymphocytic leukaemia as compared to normal subjectsAfaf Alharthi, Daniel Beck, Dena R Howard, et al.
Scientific Reports|November 13, 2019
Suppression of BCL6 function by HDAC inhibitor mediated acetylation and chromatin modification enhances BET inhibitor effects in B-cell lymphoma cellsMaría G Cortiguera, Lorena García-Gaipo, Simon D Wagner, et al.
Diagnostic Pathology|September 17, 2018
PD1Katherine Wickenden, Nadia Nawaz, Sami Mamand, et al.
Biomolecular NMR Assignments|September 21, 2017
Backbone resonance assignment of the BCL6-BTB/POZ domainLi-Ying Lin, S E Evans, L Fairall, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2013
Cap-translation inhibitor, 4EGI-1, restores sensitivity to ABT-737 apoptosis through cap-dependent and -independent mechanisms in chronic lymphocytic leukemiaShaun Willimott, Daniel Beck, Matthew J Ahearne, et al.
Plos One|January 3, 2018
Circulating Tfh1 (cTfh1) cell numbers and PD1 expression are elevated in low-grade B-cell non-Hodgkin's lymphoma and cTfh gene expression is perturbed in marginal zone lymphomaElliot T Byford, Matthew Carr, Eleni Ladikou, et al.
Blood Advances|March 1, 2019
Interleukin-2-inducible T-cell kinase inhibitors modify functional polarization of human peripheral T-cell lymphoma cellsSami Mamand, Matthew Carr, Rebecca L Allchin, et al.
Virchows Archiv : an International Journal of Pathology|July 12, 2014
Expression of PD-1 (CD279) and FoxP3 in diffuse large B-cell lymphomaMatthew J Ahearne, Kaljit Bhuller, Roger Hew, et al.
The Biochemical Journal|February 24, 2010
ZEB1 and CtBP form a repressive complex at a distal promoter element of the BCL6 locusVasiliki Papadopoulou, Antonio Postigo, Ester Sánchez-Tilló, et al.
Leukemia & Lymphoma|August 19, 2007
Bcl-6 and c-Myc are rarely co-expressed in adult diffuse large B-cell lymphomaSimon D Wagner, Furrat Amen, Pritesh S Trivedi, et al.
BMC Research Notes|May 10, 2018
An increased fraction of circulating miR-363 and miR-16 is particle bound in patients with chronic lymphocytic leukaemia as compared to normal subjectsAfaf Alharthi, Daniel Beck, Dena R Howard, et al.
Scientific Reports|November 13, 2019
Suppression of BCL6 function by HDAC inhibitor mediated acetylation and chromatin modification enhances BET inhibitor effects in B-cell lymphoma cellsMaría G Cortiguera, Lorena García-Gaipo, Simon D Wagner, et al.
Diagnostic Pathology|September 17, 2018
PD1Katherine Wickenden, Nadia Nawaz, Sami Mamand, et al.
Biomolecular NMR Assignments|September 21, 2017
Backbone resonance assignment of the BCL6-BTB/POZ domainLi-Ying Lin, S E Evans, L Fairall, et al.
Pageof 6